Pfizer Japan files 20-valent pneumococcal vaccine for older adults and individuals at high risk of contracting an infectious disease caused by pneumococcus
Pfizer has filed Apexxnar, its 20-valent pneumococcal conjugate vaccine in Japan for the prevention of pneumococcal infection in older adults and individuals at a high risk of contracting… read more.
